Middle East Clinical Nutrition Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Parenteral, Enteral, Oral), By Application (Malabsorption/GI Disorder/Diarrhea, Cancer Care), By Sales Channel (Online, Retail), By Country, And Segment Forecasts

Middle East Clinical Nutrition Market Summary

The Middle East clinical nutrition market size was estimated at USD 1,235.8 million in 2024 and is projected to reach USD 1,644.1 million by 2033, growing at a CAGR of 3.11% from 2025 to 2033. High prevalence of malnutrition, a rising burden of chronic diseases, expanding healthcare infrastructure, and a growing elderly population are some of the key drivers of this market.

According to the Global Nutrition Report, the UAE faces a major nutrition challenge, with 44.2% of women and 30.9% of men aged 18 and older classified as obese. These rates are not only alarmingly high but also significantly above the regional averages for Western Asia, which are 10.3% for women and 7.5% for men. This gap highlights that obesity has become a widespread public health issue in the UAE. Such a high prevalence points to a form of malnutrition, specifically over nutrition, that requires targeted intervention through structured nutrition strategies. Therefore, there is a growing reliance on clinical nutrition products, such as tailored oral supplements, low-calorie meal replacements, and disease-specific nutrition formulas, to help manage weight, maintain balanced nutrient intake, and support overall nutritional health.

According to the United Arab Emirates’ government portal, as of 2021, 11.8% of the UAE’s population aged 20-79 years was affected by diabetes. Reducing the prevalence of this condition is a key performance indicator under the pillar of world-class healthcare in the UAE National Agenda 2021. To address this challenge, the Ministry of Health and Prevention launched several initiatives, including the Diabetes Screening and Professional Healthcare Education program, which focused on screening 10,000 high-risk individuals and training 90 nurses through the Johnson & Johnson Diabetes Institute (JJDI) curriculum. These national efforts highlight the important role of structured care in managing diabetes, thereby increasing the demand for clinical nutrition solutions, such as specialized dietary formulas and oral nutrition supplements that support better glucose control and dietary management. As diabetes remains a major health challenge, the use of clinical nutrition products continues to grow.

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, impact of regulations, level of partnerships & collaborations activities, degree of innovation, and regional expansion. For instance, the Middle East clinical nutrition market is slightly fragmented, with many solution providers entering the market.

The degree of innovation in the Middle East clinical nutrition industry is moderate to high, driven by rising obesity and malnutrition rates, expanding healthcare infrastructure, and strong government initiatives to improve population health. Global and regional companies are introducing specialized oral nutrition supplements, enteral feeding formulas, and advanced parenteral nutrition products to meet the growing demand arising from high obesity rates, malnutrition, and rising chronic disease prevalence.

The level of partnerships in the market is moderate, with companies increasingly exploring cross-industry collaborations to expand reach and enhance consumer engagement. In March 2025, Beyond Airlines partnered with The Elixir Clinic to offer passengers IV VitaDrip therapy as a wellness add-on, showcasing how clinical nutrition is being integrated into lifestyle and travel experiences to drive market growth.

The impact of regulations on the market is high, as governments across the region enforce stringent guidelines to ensure product safety, quality, and efficacy. Regulatory bodies such as the UAE Ministry of Health and Prevention (MOHAP) and the Saudi Food and Drug Authority (SFDA) closely monitor the approval, labeling, and marketing of oral, enteral, and parenteral nutrition products. Companies must comply with international standards for nutritional content, sterility, and manufacturing practices, while also aligning with regional policies that promote healthier diets and reduce malnutrition.

The level of expansion in the clinical nutrition industry is moderate, supported by growing investments in healthcare infrastructure and government-backed initiatives to address malnutrition and lifestyle-related health challenges.

Product Insights

The oral nutrition segment held the largest revenue share of 64.6% in 2024. The rising prevalence of malnutrition among the adult population and the increasing instances of obesity and chronic diseases such as cancer and diabetes are some of the major factors boosting the market growth. The market leaders and innovators are involved in novel product launches to enhance productivity, durability, and quality, and improve the nutritional value of the food products. Along with the nutritional value, the manufacturers of clinical nutrition products are working to enhance and improve the taste of the products by incorporating different flavors.

The parenteral nutrition segment is expected to grow at the fastest CAGR over the forecast period. Development of technically advanced parenteral nutrition (PN) products with barcode assistance, growing preference for PN over enteral nutrition in patients, shorter hospital stays, and reduced risk of infection are some of the factors boosting the product demand, thereby driving the market growth.

Application Insights

The cancer care segment holds the largest share of the clinical nutrition market, as oncology patients often experience severe weight loss, malnutrition, and difficulty in maintaining adequate nutrient intake due to the disease and treatment side effects such as loss of appetite, nausea, or swallowing difficulties. This drives strong demand for specialized enteral and parenteral nutrition solutions that support strength, recovery, and treatment tolerance, making cancer care a primary focus area for clinical nutrition providers.

The malabsorption/GI Disorder/Diarrhea segment is anticipated to grow at the fastest CAGR over the forecast period. Malabsorption typically means difficulty in digesting nutrients that are provided through food. Certain conditions are known to cause malabsorption, such as short bowel syndrome, cystic fibrosis, chronic pancreatitis, and Crohn’s disease. It can also lead to other illnesses if proper nutrients are unavailable in the body. In these cases, enteral nutrition via oral or tube/enteral feeding plays a vital role. It provides the body with necessary nutrients and helps in improving gut immunity.

Sales Channel Insights

The institutional sales channel segment held the largest market share in 2024. Institutions that purchase clinical nutrition products include hospitals, long-term care centers, hospices, and disability facilities. The purchase decision of enteral or parenteral nutrition is influenced by doctors. Furthermore, the growing number of private and public institutions and the increasing chronic disease patient population across the globe are propelling the segment.

The online sales channel segment is anticipated to witness the fastest growth during the forecast period. There is a shift in the trend of direct selling to customers via e-commerce platforms. The preference for online purchase of enteral feeding formula is rising owing to the convenience offered by this sales channel. Although consumed under medical surveillance, these products are intended for long-term nutrition management, resulting in growing sales through e-commerce.

Regional Insights

UAE Clinical Nutrition Market

The UAE clinical nutrition market is growing steadily, driven by rising rates of obesity, diabetes, and malnutrition, alongside government initiatives aimed at improving population health and promoting preventive care. For instance, in June 2025, the UAE Ministry of Health and Prevention launched the National Clinical Guideline for Weight Management and Prevention of Adulthood Obesity, providing a comprehensive framework to reduce chronic diseases and foster well-being through nutrition, physical activity, behavioral change, and medical intervention strategies. This initiative, aligned with the UAE’s long-term health vision, is expected to boost the adoption of specialized clinical nutrition solutions in hospitals, clinics, and home care settings, while strong regulatory oversight and healthcare investments further support market expansion.

Saudi Arabia Clinical Nutrition Market

The clinical nutrition market in Saudi Arabia is driven by the country’s high burden of obesity, diabetes, and other lifestyle-related conditions that create significant demand for specialized nutritional support. Government initiatives under Saudi Vision 2030 to modernize healthcare infrastructure and reduce chronic disease prevalence are further boosting the adoption of advanced enteral and parenteral nutrition solutions.

Kuwait Clinical Nutrition Market

The clinical nutrition market in Kuwait is projected to grow steadily, driven by increasing demand for specialized nutritional products such as oral and enteral nutrition, supported by a rising geriatric population and growing prevalence of chronic diseases like cancer. The government’s focus on strengthening preventive healthcare and reducing the burden of non-communicable diseases aligns with the growing adoption of enteral and parenteral nutrition solutions across hospitals and home care settings.

Key Middle East Clinical Nutrition Companies Insights

Key players operating in the Middle East clinical nutrition market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In September 2022, REVIV UAE partnered with CRYO to offer a holistic wellness approach combining signature IV nutrient therapy with advanced cryotherapy treatments across their four luxury locations in Dubai and Abu Dhabi. This collaboration aims to enhance healing, recovery, and overall wellness by integrating nutrient therapy with cryotherapy's performance and recovery benefits.

• In May 2022, the Abu Dhabi Health Services Company (SEHA) hosted the inaugural Middle Eastern Society for Parenteral and Enteral Nutrition (MESPEN) Congress, a landmark multidisciplinary gathering designed to elevate clinical nutrition practices across inpatient, outpatient, and homecare settings in the region.

Middle Clinical NutritionMarket Report Scope

Middle Clinical Nutrition Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East clinical nutrition market report based on product, application, sales channel, and country.

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Oral Clinical Nutrition

  • Parenteral Nutrition

    • Carbohydrates

    • Parenteral Lipid Emulsion

    • Single Dose Amino Acid Solutions

    • Trace Elements

    • Vitamins & Minerals

  • Enteral Feeding Formulas

    • Standard Formula

    • Disease-specific Formulas

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Online Sales Channels

  • Retail Sales Channel

  • Institutional Sales Channel

• Country Outlook (Revenue, USD Million, 2021 - 2033)

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman